FDA Fast Tracks ALS Stem Cell Therapy (BioNews)

 

(Washington, DC) The United States food and drug administration FDA has granted fast-track status for a potential stem cell treatment of amyotrophic lateral sclerosis ALS.

PUBMED ARTICLES CLINICAL TRIALS